// App-Quantinova.ai

84 P-3-770 : Particularites de la prise en charge du diabete Type 1 chez des enfants dont la revelation est survenue avant -age de five ans

Researchers

Presenter

  • Mazari Wafaa

Principal Investigators

  • Bouriche Khadidja

  • Senouci Djawida

  • Zerga Yasmine

  • Chiali Snaa

  • Bendeddouche Salih

Medical Centers

  • ChU Tlemcen, Tlemcen, Algeria

Locations

  • Algeria

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Hemoglobin A1c

  • Insulin-like growth factor 1

Drug/Treatment

  • ReVele

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved